John H. Gordon

1.1k total citations
30 papers, 787 citations indexed

About

John H. Gordon is a scholar working on Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, John H. Gordon has authored 30 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Genetics. Recurrent topics in John H. Gordon's work include Estrogen and related hormone effects (9 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Receptor Mechanisms and Signaling (7 papers). John H. Gordon is often cited by papers focused on Estrogen and related hormone effects (9 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Receptor Mechanisms and Signaling (7 papers). John H. Gordon collaborates with scholars based in United States. John H. Gordon's co-authors include Roger A. Gorski, Jeremy Z. Fields, Brian F. McCabe, Dwight M. Nance, Bruce I. Diamond, Marilyn Y. McGinnis, Richard L. Borison, Cleatus J. Wallis, E. Zimmermann and Mark M. Rasenick and has published in prestigious journals such as Neurology, Cancer and Brain Research.

In The Last Decade

John H. Gordon

30 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John H. Gordon United States 17 272 222 195 179 175 30 787
Ar Genazzani Italy 17 140 0.5× 287 1.3× 164 0.8× 210 1.2× 271 1.5× 40 917
OK Rönnekleiv United States 10 204 0.8× 114 0.5× 246 1.3× 165 0.9× 105 0.6× 12 613
Mark D. Fitzsimmons United States 11 166 0.6× 102 0.5× 174 0.9× 67 0.4× 119 0.7× 12 636
Naoto Minamitani Japan 17 301 1.1× 456 2.1× 124 0.6× 59 0.3× 114 0.7× 31 853
Héctor Coirini Argentina 20 196 0.7× 321 1.4× 219 1.1× 146 0.8× 396 2.3× 39 1.2k
Jenn-Tser Pan Taiwan 14 289 1.1× 114 0.5× 249 1.3× 75 0.4× 117 0.7× 48 684
T Nogimori Japan 15 177 0.7× 235 1.1× 79 0.4× 61 0.3× 93 0.5× 89 760
D.M. Gibbs United States 10 127 0.5× 145 0.7× 135 0.7× 38 0.2× 165 0.9× 12 620
E.E. Müller Italy 19 234 0.9× 731 3.3× 124 0.6× 108 0.6× 117 0.7× 50 1.3k
David K. Sundberg United States 16 189 0.7× 137 0.6× 128 0.7× 30 0.2× 173 1.0× 34 729

Countries citing papers authored by John H. Gordon

Since Specialization
Citations

This map shows the geographic impact of John H. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Gordon more than expected).

Fields of papers citing papers by John H. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Gordon. The network helps show where John H. Gordon may publish in the future.

Co-authorship network of co-authors of John H. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Gordon. A scholar is included among the top collaborators of John H. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Gordon. John H. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drucker, George E., et al.. (1994). Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): Biphasic dose-response curves. Pharmacology Biochemistry and Behavior. 47(1). 141–145. 7 indexed citations
2.
Levin, Robert D. & John H. Gordon. (1993). Fluorodeoxyuridine with continuous leucovorin infusion a phase ii clinical trial in patients with metastatic colorectal cancer. Cancer. 72(10). 2895–2901. 6 indexed citations
3.
Fields, Jeremy Z., et al.. (1991). Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity. Pharmacology Biochemistry and Behavior. 40(4). 881–886. 9 indexed citations
4.
Fields, Jeremy Z. & John H. Gordon. (1991). Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat. Brain Research Bulletin. 26(4). 549–552. 3 indexed citations
5.
Fields, Jeremy Z., et al.. (1991). Neurochemical Basis for the Absence of Overt “Stereotyped” Behaviors in Rats With Up-Regulated Striatal D2 Dopamine Receptors. Clinical Neuropharmacology. 14(3). 199–208. 4 indexed citations
6.
Fields, Jeremy Z., et al.. (1991). Cyclo(leu‐gly) reverses the permanent dopamine receptor up‐regulation induced by ovariectomy. Drug Development Research. 23(3). 261–268. 2 indexed citations
7.
8.
Koller, William C., et al.. (1987). PHNO, a novel dopamine agonist, in animal models of parkinsonism. Movement Disorders. 2(3). 193–199. 8 indexed citations
9.
Gordon, John H., et al.. (1985). The possible role of 2-hydroxyestradiol in the development of estrogen-induced striatal dopamine receptor hypersensitivity. Brain Research. 333(1). 1–10. 48 indexed citations
10.
Gordon, John H., et al.. (1983). Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity. Brain Research Bulletin. 10(4). 425–428. 73 indexed citations
11.
Gordon, John H.. (1983). Hypophysectomy-induced striatal hypersensitivity and mesolimbic hyposensitivity to apomorphine. Pharmacology Biochemistry and Behavior. 19(5). 807–811. 10 indexed citations
12.
Gordon, John H., Roger A. Gorski, Richard L. Borison, & Bruce I. Diamond. (1980). Postsynaptic efficacy of dopamine: Possible suppression by estrogen. Pharmacology Biochemistry and Behavior. 12(4). 515–518. 47 indexed citations
13.
McGinnis, Marilyn Y., John H. Gordon, & Roger A. Gorski. (1980). Influence of γ-aminobutyric acid on lordosis behavior and dopamine activity in estrogen primed spayed female rats. Brain Research. 184(1). 179–191. 25 indexed citations
14.
Gordon, John H.. (1980). Modulation of apomorphine-induced stereotypy by estrogen: Time course and dose response. Brain Research Bulletin. 5(6). 679–682. 78 indexed citations
15.
Gordon, John H., Richard L. Borison, & Bruce I. Diamond. (1980). Estrogen in experimental tardive dyskinesia. Neurology. 30(5). 551–551. 25 indexed citations
16.
Gordon, John H., et al.. (1978). Δ 9 -Tetrahydrocannabinol enhancement of Lordosis Behavior in estrogen treated female rats. Pharmacology Biochemistry and Behavior. 8(5). 603–608. 58 indexed citations
17.
Gordon, John H., Dwight M. Nance, Cleatus J. Wallis, & Roger A. Gorski. (1977). Effects of estrogen on dopamine turnover, glutamic acid decarboxylase activity and lordosis behavior in septal lesioned female rats. Brain Research Bulletin. 2(5). 341–346. 46 indexed citations
18.
Nance, Dwight M., James E. Shryne, John H. Gordon, & Roger A. Gorski. (1977). Examination of some factors that control the effects of septal lesions on lordosis behavior. Pharmacology Biochemistry and Behavior. 6(2). 227–234. 35 indexed citations
19.
Randić, Mirjana, et al.. (1976). Spinal localization of neurons receiving inputs from cutaneous afferents in the cat hindlimb. Brain Research. 105(3). 573–577. 20 indexed citations
20.
Ashbaugh, David G. & John H. Gordon. (1975). Traumatic avulsion of the trachea associated with cricoid fracture. Journal of Thoracic and Cardiovascular Surgery. 69(5). 800–803. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ar Genazzani Breakdown of academic impact, for papers by OK Rönnekleiv Breakdown of academic impact, for papers by Mark D. Fitzsimmons Breakdown of academic impact, for papers by Naoto Minamitani Breakdown of academic impact, for papers by Héctor Coirini Breakdown of academic impact, for papers by Jenn-Tser Pan Breakdown of academic impact, for papers by T Nogimori Breakdown of academic impact, for papers by D.M. Gibbs Breakdown of academic impact, for papers by E.E. Müller Breakdown of academic impact, for papers by David K. Sundberg
Rankless by CCL
2026